[1]
MICHAEL and RAMATILLAH, D.L. 2022. TREATMENT PROFILE AND SURVIVAL ANALYSIS ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) COVID-19 PATIENTS. International Journal of Applied Pharmaceutics. 14, 2 (Apr. 2022), 54–56. DOI:https://doi.org/10.22159/ijap.2022.v14s2.44750.